1. Home
  2. SVRA vs RYAM Comparison

SVRA vs RYAM Comparison

Compare SVRA & RYAM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SVRA
  • RYAM
  • Stock Information
  • Founded
  • SVRA 2007
  • RYAM 1926
  • Country
  • SVRA United States
  • RYAM United States
  • Employees
  • SVRA N/A
  • RYAM N/A
  • Industry
  • SVRA Biotechnology: Pharmaceutical Preparations
  • RYAM Paper
  • Sector
  • SVRA Health Care
  • RYAM Basic Materials
  • Exchange
  • SVRA Nasdaq
  • RYAM Nasdaq
  • Market Cap
  • SVRA 527.2M
  • RYAM 477.7M
  • IPO Year
  • SVRA N/A
  • RYAM N/A
  • Fundamental
  • Price
  • SVRA $3.60
  • RYAM $7.41
  • Analyst Decision
  • SVRA Buy
  • RYAM Buy
  • Analyst Count
  • SVRA 8
  • RYAM 1
  • Target Price
  • SVRA $6.63
  • RYAM $6.00
  • AVG Volume (30 Days)
  • SVRA 1.1M
  • RYAM 691.8K
  • Earning Date
  • SVRA 11-11-2025
  • RYAM 11-04-2025
  • Dividend Yield
  • SVRA N/A
  • RYAM N/A
  • EPS Growth
  • SVRA N/A
  • RYAM N/A
  • EPS
  • SVRA N/A
  • RYAM N/A
  • Revenue
  • SVRA N/A
  • RYAM $1,519,622,000.00
  • Revenue This Year
  • SVRA N/A
  • RYAM N/A
  • Revenue Next Year
  • SVRA N/A
  • RYAM $4.65
  • P/E Ratio
  • SVRA N/A
  • RYAM N/A
  • Revenue Growth
  • SVRA N/A
  • RYAM N/A
  • 52 Week Low
  • SVRA $1.89
  • RYAM $3.35
  • 52 Week High
  • SVRA $4.30
  • RYAM $10.28
  • Technical
  • Relative Strength Index (RSI)
  • SVRA 61.30
  • RYAM 67.19
  • Support Level
  • SVRA $3.35
  • RYAM $7.06
  • Resistance Level
  • SVRA $3.53
  • RYAM $7.89
  • Average True Range (ATR)
  • SVRA 0.13
  • RYAM 0.32
  • MACD
  • SVRA -0.03
  • RYAM -0.08
  • Stochastic Oscillator
  • SVRA 72.31
  • RYAM 62.07

About SVRA Savara Inc.

Savara Inc is a biopharmaceutical company. It is focused on rare respiratory diseases. The company's program, molgramostim nebulizer solution (molgramostim), is an inhaled granulocyte-macrophage colony-stimulating factor in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP). It has one segment specialty pharmaceuticals within the respiratory system.

About RYAM Rayonier Advanced Materials Inc.

Rayonier Advanced Materials Inc is engaged in the production of cellulose specialties, a natural polymer used in the manufacturing of various specialty chemical products, including liquid crystal displays, filters, textiles and performance additives for pharmaceutical, food and other industrial applications. The company's products are used in a variety of applications, including cigarette filters, liquid crystal displays, paints, pharmaceuticals, and food. The company operates in the reportable segments of High Purity Cellulose, Paperboard, and High-Yield Pulp. The key revenue is derived from the High Purity Cellulose segment. Geographically, it derives a majority of its revenue from the United States.

Share on Social Networks: